Kadensa Capital Trims Tempus AI Stake Amid Institutional Divergence
Kadensa Capital Ltd reduced its position in Tempus AI (TEM) by 4.8% during the third quarter, signaling a tactical adjustment by the institutional investor. This move comes as the precision medicine firm sees high volatility and divergent sentiment among major funds, including aggressive buying from ARK Invest.